Genetic counseling and cascade genetic testing in Lynch syndrome
- 11 March 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Familial Cancer
- Vol. 15 (3), 423-427
- https://doi.org/10.1007/s10689-016-9893-5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialThe Lancet, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- The PREMM1,2,6 Model Predicts Risk of MLH1, MSH2, and MSH6 Germline Mutations Based on Cancer HistoryGastroenterology, 2011
- Development and Validation of a Colon Cancer Risk Assessment Tool for Patients Undergoing ColonoscopyThe American Journal of Gastroenterology, 2009
- Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relativesGenetics in Medicine, 2009
- EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeGenetics in Medicine, 2009
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- Sharing Genetic Test Results in Lynch Syndrome: Communication With Close and Distant RelativesClinical Gastroenterology and Hepatology, 2008
- Validation and Extension of the PREMM1,2 Model in a Population-Based Cohort of Colorectal Cancer PatientsGastroenterology, 2008
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991